PGNY

New York, NY, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Thor Equities Group, a global leader in real estate investment, development, and management, announced today that it has officially closed on its $217.5 million acquisition of 1359 Broadway, a 22-story, 486,000-square-foot office building in Midtown Manhattan. Located at the intersection of Broadway and West 36th Street, just North of Herald Square,

Guidance cut puts Progyny’s recent move in context Progyny (PGNY) reset the conversation for investors after trimming its full year revenue outlook to a range of $1.36b to $1.385b, citing softer utilization patterns than usual summer seasonality. Management framed the revised guidance as a response to near term headwinds rather than a signal of weaker long run demand for fertility and family build

Progyny has delivered a sharp 56.1% share price gain over the past year, and that kind of run naturally raises a simple question for holders and onlookers alike. Is the current valuation still grounded in what the business is earning, or has the price moved ahead of its fundamentals? The 56.1% return over the last 12 months puts Progyny in a very different place from three and five years ago. This

Progyny cut its 2026 revenue guidance to US$1.36b to US$1.385b after softer than expected fertility benefit utilization that management framed as seasonal rather than structural. The company still points to encouraging early interest for the 2027 selling season, which could test how employers view long term fertility and women's health benefits. The focus now turns to how Progyny's investment narr

The Easterly Snow Capital Small Cap Value Fund is a U.S. open-end equity mutual fund managed by Easterly Asset Management, sub-advised by Snow Capital Management. The letter can be downloaded here. The Easterly Snow Small Cap Value Fund fell 4.04% in Q3 2026, outperforming both the Bloomberg US 2000 Value Index (-7.26%) and Russell 2000 […]

PGNY pairs strong profitability and zero debt with a bull flag setup, offering a growth screen candidate with fundamentals and technicals aligned.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

What a fantastic six months it’s been for Progyny. Shares of the company have skyrocketed 51.1%, hitting $27.77. This performance may have investors wondering how to approach the situation.